Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:47 PM
Ignite Modification Date:
2025-12-24 @ 10:47 PM
NCT ID:
NCT03417869
Eligibility Criteria:
Inclusion Criteria:
Subjects will be recruited from the general population as they present to the clinical facility. Subjects must have had a fever within the last two days and exhibiting one or more symptoms characteristic of influenza. They must meet the following criteria to be eligible for enrollment:
1. Male or Female of all ages (with appropriate consent).
2. The subject must have had of a fever, ≥ 37.8º C (100º F), within the last two days.
3. Must also be currently exhibiting one or more of the following symptoms characteristic of influenza-like-illness (ILI).
1. Nasal congestion
2. Rhinorrhea
3. Sore throat
4. Cough
5. Headache
6. Myalgia
7. Malaise
Exclusion Criteria:
* 1\. Has undergone treatment with anti-influenza antivirals within the previous 7 days, to include but not be limited to, Amantadine, Rimantadine, Ribavirin, Oseltamivir, Zanamivir or any other antiviral currently available in these classes.
2\. Has been vaccinated by means of an influenza nasal spray/mist vaccine within the previous 7 days.
3\. Unable to understand and consent to participation; for minors this includes parent or legal guardian.
Healthy Volunteers:
False
Sex:
ALL
Study:
NCT03417869
Study Brief:
Protocol Section:
NCT03417869